Dual Inhibitors of PARPs and ROCKs
ACS Omega. 2018 Oct 31;3(10):12707-12712. doi: 10.1021/acsomega.8b02337.…
CAR-T Cells and Oncolytic Viruses: Joining Forces to Overcome the Solid Tumor Challenge
Front Immunol. 2018 Oct 23;9:2460. doi: 10.3389/fimmu.2018.02460.…
Influence of age and spectral power distribution on mesopic visual sensitivity
Atten Percept Psychophys. 2019 Feb;81(2):504-516. doi: 10.3758/s13414-018-1616-6.ABSTRACTThe…
Disease networks identify specific conditions and pleiotropy influencing multimorbidity in the general population
Sci Rep. 2018 Oct 29;8(1):15970. doi: 10.1038/s41598-018-34361-3.ABSTRACTMultimorbidity…
Translational Research Opportunities Regarding Homologous Recombination in Ovarian Cancer
Int J Mol Sci. 2018 Oct 19;19(10):3249. doi: 10.3390/ijms19103249.ABSTRACTHomologous…
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party
Cancer. 2019 Jan 1;125(1):90-98. doi: 10.1002/cncr.31755. Epub…
Bioselection Reveals miR-99b and miR-485 as Enhancers of Adenoviral Oncolysis in Pancreatic Cancer
Mol Ther. 2019 Jan 2;27(1):230-243. doi: 10.1016/j.ymthe.2018.09.016.…
Plasma Energy-Balance Metabolites Discriminate Asymptomatic Patients with Peripheral Artery Disease
Mediators Inflamm. 2018 Sep 20;2018:2760272. doi: 10.1155/2018/2760272.…
Enhanced Antitumor Efficacy of Oncolytic Adenovirus-loaded Menstrual Blood-derived Mesenchymal Stem Cells in Combination with Peripheral Blood Mononuclear Cells
Mol Cancer Ther. 2019 Jan;18(1):127-138. doi: 10.1158/1535-7163.MCT-18-0431.…
Decreased RORC expression and downstream signaling in HTLV-1-associated adult T-cell lymphoma/leukemia uncovers an antiproliferative IL17 link: A potential target for immunotherapy?
Int J Cancer. 2019 Apr 1;144(7):1664-1675. doi: 10.1002/ijc.31922.…
Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma
Oncotarget. 2018 Aug 31;9(68):33043-33049. doi: 10.18632/oncotarget.25984.…
A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients
Hum Gene Ther. 2019 Mar;30(3):352-364. doi: 10.1089/hum.2018.107.…
